• 54,643+ CME Conference Registrations Sold
  • 163,929+ Medical Conferences
  • 284 Specialties
  • 11,702 Organizers
  • 159,405 Speakers
  • 159 Countries
  • 4,842 Cities
Duration: CME/CE Points: Author(s):
-
CME : 1
-

The Role of Radiation Therapy In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma is organized by American Society for Radiation Oncology (ASTRO) and will be held from Jan 31, 2018 - Jan 30, 2020.

The target audience for this medical event is radiation oncologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credit.

Provides practitioners with clear guidelines for managing relapsed lymphomas and clear information about new targeted agents now in regular use.

Learning Objectives :
Upon completion of this activity, participants should be able to:
• Define the appropriate use of radiation in the management of refractory lymphoma.

Additional details will be posted as soon as they are available.

Intended Audience

Radiation Oncology, Haematology

Fees

Activity Fee : USD $30.00
Interested

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended